METHOD THERAPEUTICS SL
Company details
- Active NIF/CIF: B88409768
-
-
-
-
Address: C/ de María de Maeztu, 146, Fuencarral-El Pardo, 28049 Madrid, España See in map
-
-
Featured products:
More information on METHOD THERAPEUTICS SL
-
15/11/2023 | BORME act no.: 483918 | Register: MADRIDPérdida del caracter de unipersonalidad
-
15/11/2023 | BORME act no.: 483918 | Register: MADRIDCambio de objeto social
-
16/03/2021 | BORME act no.: 123979 | Register: MADRIDAmpliación de capital
-
16/03/2021 | BORME act no.: 123979 | Register: MADRIDModificaciones estatutarias
-
18/07/2019 | BORME act no.: 311583 | Register: MADRIDConstitución
-
18/07/2019 | BORME act no.: 311583 | Register: MADRIDDeclaración de unipersonalidad
-
18/07/2019 | BORME act no.: 311583 | Register: MADRIDNombramientos
Other information
The CIF assigned to METHOD THERAPEUTICS SL is B88409768, and its current business status is active. The company is engaged in economic activities classified under the CNAE 2120 - Fabricación de especialidades farmacéuticas, while its SIC - is also applicable. Regarding personnel, METHOD THERAPEUTICS SL employs approximately Between 1 and 9 employees and generates an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Madrid and has a total of 2 registered positions. The latest announcement of METHOD THERAPEUTICS SL in the Borme was published on 15/11/2023, and its most recent ordinary annual accounts deposit is from the year 2022. To obtain contact information for METHOD THERAPEUTICS SL, such as telephone number, postal address, or website, you can visit the Company Data module. If you wish to obtain more details about METHOD THERAPEUTICS SL, you can review one of our available financial reports, examine the company's Annual Accounts, or check for any registered defaults in the RAI delinquency file. The financial, business, and legal information provided about METHOD THERAPEUTICS SL is official and updated daily.
Do you want to know more about METHOD THERAPEUTICS SL??
Find out more about this company by consulting these reports: